K. S. Aminu, A. Uzairu, Anshuman Chandra, Nagendra Singh, S. Abechi, G. Shallangwa, A. B. Umar
{"title":"探索 2-芳基苯并咪唑支架作为新型 α 淀粉酶抑制剂的潜力:QSAR、分子对接、模拟和药代动力学研究","authors":"K. S. Aminu, A. Uzairu, Anshuman Chandra, Nagendra Singh, S. Abechi, G. Shallangwa, A. B. Umar","doi":"10.1007/s40203-024-00205-4","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":94038,"journal":{"name":"In silico pharmacology","volume":"94 6","pages":"1-22"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Exploring the potential of 2-arylbenzimidazole scaffolds as novel α-amylase inhibitors: QSAR, molecular docking, simulation and pharmacokinetic studies\",\"authors\":\"K. S. Aminu, A. Uzairu, Anshuman Chandra, Nagendra Singh, S. Abechi, G. Shallangwa, A. B. Umar\",\"doi\":\"10.1007/s40203-024-00205-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":94038,\"journal\":{\"name\":\"In silico pharmacology\",\"volume\":\"94 6\",\"pages\":\"1-22\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"In silico pharmacology\",\"FirstCategoryId\":\"0\",\"ListUrlMain\":\"https://doi.org/10.1007/s40203-024-00205-4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"In silico pharmacology","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.1007/s40203-024-00205-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Exploring the potential of 2-arylbenzimidazole scaffolds as novel α-amylase inhibitors: QSAR, molecular docking, simulation and pharmacokinetic studies